UNLIMITED TURBO BULL - GSK PLC Stock

Certificat

HA52S

DE000SD3LUN6

Market Closed - Euronext Paris 12:30:01 2024-04-26 pm EDT
4.958 EUR +4.62% Intraday chart for UNLIMITED TURBO BULL - GSK PLC
Current month-12.08%
1 month-9.80%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart GSK PLC
Chart UNLIMITED TURBO BULL - GSK PLC
Date Price Change Volume
24-04-26 4.941 +4.26% 102
24-04-25 4.739 +0.96% 104
24-04-24 4.694 -4.15% 107
24-04-23 4.897 +4.35% 107
24-04-22 4.693 +9.57% 119

Real-time Euronext Paris

Last update April 26, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying GSK PLC
IssuerLogo Issuer Société Générale Société Générale
HA52S
ISINDE000SD3LUN6
Date issued 2021-02-05
Strike 1,237 p
Maturity Unlimited
Parity 1 : 1
Emission price 1.78
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.079
Lowest since issue 0.69

Company Profile

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes more than 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases.
Sector
-
More about the company

Ratings for GSK plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: GSK plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
16.53 GBP
Average target price
20.06 GBP
Spread / Average Target
+21.34%
Consensus
  1. Stock Market
  2. Certificates
  3. HA52S Certificat